drugset / Trial / NCT04642404
CBD for Dental Pain
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaulate CBD as a therapeutic approach for dental pain. Eligible subjects presented with emergency dental pain will be give a single dose of Epidiolex (FDA-approved CBD) or placebo and will be monitored for 3 hours for pain symptoms and psychologic effects.
Timeline
- Start
- 2021-03-01
- Primary completion
- 2023-03-02
- Completion
- 2023-03-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cannabidiol | Other / unclassified | 10 mg/kg | Oral |
| Subject | Cannabidiol | Other / unclassified | 20 mg/kg | Oral |